Advertisement

Topics

Search Results for "Brilinta Sales"

05:03 EDT 18th August 2017 | BioPortfolio

Matching Channels

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Sales Jobs

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

Matching News

AZ withdraws Brilinta batch for containing the wrong drug after packaging mix-up

The United Arab Emirates Ministry of Health and Prevention has called for the withdrawal of a batch of AstraZeneca’s cardiovascular drug Brilinta (ticagrelor) 90mg with immediate effect, after it wa...

AstraZeneca recalls physician sample bottles of BRILINTA heart drug

AstraZeneca said that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of BRILINTA (ticagrelor) 90mg tablets as a precautionary measure.

Brilinta/Bydureon’s Measurable Outcomes Are Smooth Fit For Contracts

Three-year contracts between AstraZeneca and Harvard Pilgrim focus on reduced hospitalization for Brilinta, reaching HbA1c goals for Bydureon; choosing appropriate...   

Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 - Due to Report of Another Medicine in One Bottle

Audience: Family Practice, Health Professional, Consumers ISSUE: AstraZeneca is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles c...

Harvard Pilgrim Signs Outcomes-Based Contracts With AstraZeneca PLC For Brilinta And Bydureon

  Life Sciences Jobs   ...

AstraZeneca PLC Initiates Voluntary Nationwide Recall Of One Lot Of BRILINTA 90mg Professional Sample Bottles Due To Report Of Another Medicine In One Bottle From That Lot

  Life Sciences Jobs   ...

Ticagrelor (BRILINTA) Professional Samples Recalled, 1 Lot

One lot of sample bottles with eight 90-mg tablets of the widely used antiplatelet is being recalled after reports that one such bottle also contained pills of a drug for gout. Heart...

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

Voluntary recall limited to Lot # JB5047 of BRILINTA® (ticagrelor) 90mg tablets, 8-count Professional (Physician) Sample Bottles Other forms or dosage strengths o...

Matching PubMed Articles

Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

To determine the prevalence of nonprescription naloxone and sterile syringe sales, factors associated with nonprescription sales, geospatial access to nonprescription naloxone and syringe-selling phar...

Policy coherence, integration, and proportionality in tobacco control: Should tobacco sales be limited to government outlets?

Multiple factors, including marijuana decriminalization/legalization, tobacco endgame discourse, and alcohol industry pressures, suggest that the retail regulatory environment for psychoactive or addi...

Impact of CVS Pharmacy's Discontinuance of Tobacco Sales on Cigarette Purchasing (2012-2014).

To assess the impact of CVS Health's discontinuation of tobacco sales on cigarette purchasing.

Drawing the Line.

Politicians have long touted giving consumers the ability to buy health insurance across state lines as part of health care reform. Several states have passed laws of their own allowing interstate sal...

Trends in Sales of Flavored and Menthol Tobacco Products in the United States during 2011-2015.

Flavors can mask the harshness of tobacco and make it appealing to young people. This study assessed flavored and menthol tobacco product sales at the national and state levels.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement